- Home
- FENC vs WLII Comparison
FENC vs WLII Comparison
Compare FENC & WLII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$10.49
Company Overview
Basic Information| Metric | FENC | WLII |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.8M | 205.1M |
| IPO Year | 2010 | 2026 |
Fundamental Metrics
Financial Performance| Metric | FENC | WLII |
|---|---|---|
| Price | $10.49 | $10.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 248.3K | 55.9K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $65.12 | N/A |
| Revenue Next Year | $41.08 | N/A |
| P/E Ratio | $1,031.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $10.16 |
| 52 Week High | $11.31 | $10.29 |
Technical Indicators
Market Signals| Indicator | FENC | WLII |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 78.57 |
| Support Level | $7.40 | $10.16 |
| Resistance Level | $11.31 | $10.29 |
| Average True Range (ATR) | 0.54 | 0.03 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 61.64 | 76.92 |
Price Performance
Historical Comparison FENC
WLII
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About WLII Willow Lane Acquisition Corp. II Class A Ordinary Shares
Willow Lane Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.